AbbVie

ABBV 86.01
1.13 (1.3%)

9 x 86.01 = 774.09
x $86.01 =

NYSE: ABBV $159 Billion Large-Cap. S&P 500. XLV Top Holding. Health Care Sector. Biotech & Pharma Industry. 5 Year Return 54%. 1 Year Return 19%. 2020 YTD Return 3%. 5.4% dividend yield. 32 total dividend payments. Current Ex-Date in 20 days on Wed, Oct 14. Wed, Oct 14. Dividend Aristocrat. 25+ consecutive years of increasing dividends. Since Earnings 9%. Compare & Contrast ABBV vs ABT.

ST

External Links

Free Channels & more...

For Starters

Charts

image
image

52WL $62.55

The 52 Week Low is $62.55 set on Mon, Mar 23, 2020.

52WH $101.28

The 52 Week High is $101.28 set on Fri, Jul 17, 2020.

ATH $125.86

The All-Time High is $125.86 set on Fri, Jan 26, 2018.

52 Week Range

$62.55
$101.28
Mar 23, 2020
Jul 17, 2020

Earnings

-0.46

Earnings Per Share

22.14

Price To Earnings Ratio


Q1 Earnings for Jan, Feb & Mar

Fri, May 1, 2020

Since Q1 Earnings Report

ABBV 6.0%


Q2 Earnings for Apr, May & Jun

Fri, Jul 31, 2020

Since Q2 Earnings Report

ABBV 9.3%

Dividends

5.42

Dividend Yield

4.72

Dividend Rate

Wed, Oct 14, 2020

Ex-Dividend Date

Mon, Nov 16, 2020

Dividend Payment Date

Quarterly

Dividend Frequency

32

Dividend History

Profile

AbbVie trades on the NYSE. ABBV's market cap is 153.8 Billion.

AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013. The recent announced acquisition of Allergan will add several new drugs in aesthetics and women's health.

Website

Related

Account Channels

Sign in to track your portfolio and more.